Concepedia

Valentijn Vergote

VV

Statistics

Publications

42

Citations

2.2K

H-Index

24

Active since

2006

Affiliations

KU Leuven(Current)

Rega Institute for Medical Research

Ghent University

Global Virus Network

University of Antwerp

Valentijn Vergote is an author at KU Leuven specializing in virology, life sciences, and molecular virology.

ORCID

Publications per year

2006–2023

42

Publications

42

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters

Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein et al. · Nature Communications · 2020 · 292 citations · Full text

, , +17

Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity

Suzanne J. F. Kaptein, Sofie Jacobs, Lana Langendries et al. · Proceedings of the National Academy of Sciences · 2020 · 287 citations · Full text

, , +17

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

Lorena Sánchez-Felipe, Thomas Vercruysse, Sapna Sharma et al. · Nature · 2020 · 191 citations · Full text

, , +17

Hantaviridae: Current Classification and Future Perspectives

Lies Laenen, Valentijn Vergote, Charles H. Calisher et al. · Viruses · 2019 · 151 citations · Full text

, , +17

The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model

Rana Abdelnabi, Caroline S. Foo, Suzanne J. F. Kaptein et al. · EBioMedicine · 2021 · 145 citations · Full text

, , +16

1–5 of 42